- Quest Diagnostics (DGX -0.5%) has formed a definitive agreement to acquire Mobile Medical Examination Service (MedXM). Financial terms were not disclosed.
- MedXM is provider of home-based health risk assessments and related services.
- The acquisition will expand Quest's scale and reach in the mobile/home segment and bolster its overall capabilities in extended care.
- The transaction is expected to be completed in the Q118.
- "Closing critical gaps in patient care, and doing so when and where it's convenient for consumers, is important to health plans and essential to empowering better health," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "By joining with MedXM, we will improve our capabilities and scale in the growing extended care segments, particularly for in-home or mobile services. This acquisition also supports our journey to becoming a more consumer friendly provider. It further highlights progress in our strategy to accelerate growth through strategically aligned, accretive acquisitions, building on our robust track record as we enter the New Year."
- Now read: Quest Diagnostics (DGX) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
Original article